Intellectual property portfolio now includes 228 Patents and 153 Trademarks providing robust protection for the Company's product platforms in the rapidly growing multi-billion dollar veterinary diagnostics market ANN ARBOR, MI / ACCESS Newswire / September 18, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company offering innovative point-of-care diagnostic and therapeutic device products for equine and companion animals, today announced the issuance of four additional U.S. patents protecting its TRUVIEW and TRUFORMA diagnostic platforms. These new patents significantly strengthen Zomedica's intellectual property portfolio and enhance the Company's ability to compete and capture share in the rapidly expanding veterinary diagnostics market-currently valued at $8-11 billion and projected to grow to $17-22 billion by 2030-2032 at a 9-11% CAGR (Fortune Business Insights; Grand View Research; Polaris Market Research). The United States Patent and Trademark Office recently issued patents numbered 12,405,192 B2, 12,399,092 B2, and 12,385,815 related to the TRUVIEW Microscope..